Shunjie Xia

N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling

Junjie Xu, Zhe Wan, Minyue Tang et al. · Molecular Cancer · 2020 · 320 citations · Full text

Medicine, Cancer Biology, Oncology +17

UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinoma

Junjie Xu, Lin Ji, Yeling Ruan et al. · Signal Transduction and Targeted Therapy · 2021 · 142 citations · Full text

Life Sciences, Cell Biology, Oncology +17

miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR

Lin Ji, Zhongjie Lin, Zhe Wan et al. · Cell Death and Disease · 2020 · 90 citations · Full text

Medicine, Oncology, Pharmacology +17

LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription

Zhongjie Lin, Shunjie Xia, Yuelong Liang et al. · Theranostics · 2020 · 63 citations · Full text

Medicine, Bioinformatics, Oncology +17

Cdk5-Mediated Phosphorylation of Sirt1 Contributes to Podocyte Mitochondrial Dysfunction in Diabetic Nephropathy

Shuo Wang, Yakun Yang, Xingyu He et al. · Antioxidants and Redox Signaling · 2020 · 41 citations

Medicine, Cell Biology, Molecular Biology +17